AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2016
May 27, 2016
35221_dirs_2016-05-27_b377bcc4-571a-403a-82d6-b08ecc346bfc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2016-05-25
Reporting Person: Fitzgerald Richard F (CFO and Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-25 | Common Stock | P | 100 | — | Acquired | 100 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-25 | Warrants | $5.00 | A | 100 | Acquired | 2022-01-29 | Common Stock (100) | Indirect |
Footnotes
F1: Represents securities included within units, each unit comprised of one share of common stock and one warrant. Each warrant entitles the holder to purchase one share of the issuer's common stcok at an exercise price of $5.00 per share, subject to adjustment.
F2: The units were purchased at a price of $9.75 per unit.
More from PAVmed Inc.
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Feb 4
Regulatory Filings
2026
Jan 23